UIC
MBII

Uniplan Investment Counsel’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Uniplan Investment Counsel’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,230,280
Closed -$1.11M – 146
2021
Q3 		$1.11M Buy
1,230,280
+521,566
+74% +$628K 0.07% 134
2021
Q2 		$1.18M Buy
+708,714
New +$1.18M 0.07% 136

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Uniplan Investment Counsel's MBII Position: Q4 2021 in Review

Uniplan Investment Counsel sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2021, closing a stake of 1,230,280 shares — an estimated $1.11M sold.

Uniplan Investment Counsel first reported a position in MBII in Q2 2021 and held it in 2 quarters. The position peaked at $1.18M in Q2 2021. 74 funds tracked by Wall St. Rank hold MBII as of Q4 2021.

  • Uniplan Investment Counsel reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2021 after selling out during the quarter.
  • Uniplan Investment Counsel sold 1,230,280 Marrone Bio Innovations, Inc. shares in Q4 2021, an estimated $1.11M.
  • Uniplan Investment Counsel first reported a position in Marrone Bio Innovations, Inc. in Q2 2021 and held it in 2 quarters.
  • Uniplan Investment Counsel's Marrone Bio Innovations, Inc. position peaked at $1.18M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2021.

Based on Uniplan Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.